These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5528958)

  • 21. [Prognosis of Kahler's disease in patients treated and not treated with alkylating agents (apropos of 45 cases)].
    Saporta L; Hugon C; Rondier J; Bontoux D; Delbarre F
    Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):11-8. PubMed ID: 5079686
    [No Abstract]   [Full Text] [Related]  

  • 22. [What does a monoclonal component signify?].
    Skrede S; Stavem P
    Tidsskr Nor Laegeforen; 1973 Sep; 93(25):1788-9. PubMed ID: 4771915
    [No Abstract]   [Full Text] [Related]  

  • 23. The "abnormality" of myeloma proteins.
    Kunkel HG
    Cancer Res; 1968 Jul; 28(7):1351-3. PubMed ID: 4174341
    [No Abstract]   [Full Text] [Related]  

  • 24. [Heat precipitation in a case of myeloma].
    Englis M; Englisova M
    Nouv Rev Fr Hematol; 1968; 8(2):264-5. PubMed ID: 4232376
    [No Abstract]   [Full Text] [Related]  

  • 25. [BUN, Bence Jones protein, and chromosomal aberrations predict survival in multiple myeloma].
    Okada K; Oguchi N; Shinohara K; Tamura N; Ishii K; Noguchi Y; Hayashi S; Yamamoto H; Takeichi M; Fujimoto H; Shirota T; Hayashi T
    Rinsho Ketsueki; 1997 Dec; 38(12):1254-62. PubMed ID: 9455144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Skin and mucosal manifestations in plasmacytosis].
    Noble JP; Bolgert M
    Presse Med (1893); 1969 Mar; 77(12):431-4. PubMed ID: 5785076
    [No Abstract]   [Full Text] [Related]  

  • 27. [A case of gastric amyloidosis developing into Bence-Jones type multiple myeloma, treated effectively by cyclo-VAMP chemotherapy].
    Ayabe T; Maekawa I; Ashida T; Taruishi M; Shibata Y; Namiki M
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2399-403. PubMed ID: 8259860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of Bence Jones myeloma and monitoring of myeloma chemotherapy using immunoassays specific for free immunoglobulin light chains.
    Mead GP; Carr-Smith HD; Drayson MT; Bradwell AR
    Clin Lab; 2003; 49(1-2):25-7. PubMed ID: 12593472
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of reduced alkylated derivatives of some myeloma globulins and Bence-Jones proteins.
    POULIK MD; EDELMAN GM
    Nature; 1961 Sep; 191():1274-6. PubMed ID: 14488333
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma.
    Boccadoro M; Palumbo A; Bringhen S; Merletti F; Ciccone G; Richiardi L; Rus C; Bertola A; Giaccone L; Omedè P; Musto P
    Haematologica; 2002 Aug; 87(8):846-50. PubMed ID: 12161361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chromosome studies in a case of Bence Jones myeloma].
    Trizio D; Ferrannini A
    Haematologica; 1970 Dec; 55(12):774-7. PubMed ID: 5003117
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple-myeloma proteins. III. The antigenic relationship of Bence Jones proteins to normal gammaglobulin and multiple-myeloma serum proteins.
    KORNGOLD L; LIPARI R
    Cancer; 1956; 9(2):262-72. PubMed ID: 13304841
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative study of the melphalan and of the cyclophosphamide in the treatment of Kahler's disease].
    Bontoux D; Chenbit D; Delbarre F
    Therapeutique; 1971 Jan; 47(1):27-32. PubMed ID: 5572915
    [No Abstract]   [Full Text] [Related]  

  • 34. Proteinuria in multiple myeloma.
    Harrison JF; Blainey JD; Hardwicke J; Rowe DS; Soothill JF
    Clin Sci; 1966 Aug; 31(1):95-110. PubMed ID: 5912709
    [No Abstract]   [Full Text] [Related]  

  • 35. Factors influencing platelet recovery after blood cell transplantation in multiple myeloma.
    Gertz MA; Lacy MQ; Inwards DJ; Pineda AA; Chen MG; Gastineau DA; Tefferi A; Kyle RA; Litzow MR
    Bone Marrow Transplant; 1997 Sep; 20(5):375-80. PubMed ID: 9339752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of abnormal protein tests in multiple myeloma.
    Talavdekar RV
    Indian J Cancer; 1970 Sep; 7(3):207-18. PubMed ID: 5508530
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of early paraprotein response to vincristine-doxorubicin-dexamethasone chemotherapy may help guide therapy in multiple myeloma.
    Ross DM; To LB; Horvath N
    Intern Med J; 2004; 34(9-10):576-8. PubMed ID: 15482273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Physiopathological and cytogenetic findings in 2 cases of plasma cell leukemia].
    Masera P; Benzio G; Pagliardi GL; Tarocco RP; Gabutti V
    Minerva Med; 1970 May; 61(37):2005-12. PubMed ID: 5469250
    [No Abstract]   [Full Text] [Related]  

  • 39. Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance.
    Br J Haematol; 1973 Jan; 24(1):123-39. PubMed ID: 4805842
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of multiple myeloma. High-dose intermittent administration of cyclophosphamide and prednisolone--follow up study of 10 years period].
    Mizuno H; Ninomiya N; Ohta H; Tokoro K; Yasuma A; Ohnishi K; Ikeda Y
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2286-91. PubMed ID: 6639091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.